Share

National Press Releases

February 22, 2024

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.


 
February 14, 2024

American Cancer Society Researcher Testifies Before Congress; Advocates for the SCREENS for Cancer Act and the Women and Lung Cancer Research and Preventive Services Act.

Dr. Christina Annunziata, the Senior Vice President of Extramural Discovery Science at the American Cancer Society, testified today before the House Committee on Energy and Commerce’s Subcommittee on Health in support of the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act and the Women and Lung Research and Preventive Services Act.

January 31, 2024

25 Patient and Provider Groups Urge Supreme Court to Preserve FDA Authority

Our 25 organizations, representing patients with serious health conditions and providers who care for them, urge the Supreme Court to reverse the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al. because it threatens patients’ and providers’ ability to rely on Food and Drug Administration (FDA) decisions about drug safety.

January 29, 2024

New Report Illustrates Important Role of Medicare Program in Saving Lives from Cancer

The American Cancer Society Cancer Action Network (ACS CAN) released a new report today, Cancer in Medicare: An American Cancer Society Cancer Action Network Chartbook, to illustrate how the Medicare program serves patients across the cancer continuum as well as specific public policy recommendations to improve and strengthen the program. Given an individual’s cancer risk increases with age, Medicare plays a key role in reducing suffering and death from cancer. 

January 24, 2024

Cancer Advocates Applaud 2nd Circuit for Protecting Patients from Surprise Billing

Yesterday, the U.S. Court of Appeals for the Second Circuit issued a decision in the case of Haller v. Health and Human Services (HHS) upholding the U.S. District Court’s ruling preserving the provisions of the No Surprises Act (NSA) that prohibit patients from receiving surprise bills for unexpected out-of-network costs. However, the case was remanded back to the lower court for reconsideration of the issue of payments between providers and insurers.  

January 17, 2024

Supreme Court to Hear Oral Arguments Considering Deference to Federal Executive Agencies in Loper and Relentless Cases

Today, the Supreme Court of the United States will hear oral arguments in the case of Loper Bright Enterprises v. Raimondo and its companion case, Relentless v. Dept. of Commerce. The cases put in question the “Chevron deference” that protects the legal stability of public health programs like Medicare and Medicaid that benefit nearly half of the U.S. population by ensuring that laws passed by Congress can continue to be interpreted and implemented by expert federal agencies such as the Centers for Medicare and Medicaid Services (CMS).